ImmunoPET Imaging of CTLA-4 Expression in Mouse Models of Non-Small Cell Lung Cancer

Molecular Pharmaceutics- United States

doi 10.1021/acs.molpharmaceut.7b00056

Full Text

Abstract

Available in

Date

Authors

Publisher

American Chemical Society (ACS)

Related search

Prevalence of DLL3, CTLA-4 and MSTN Expression in Patients With Small Cell Lung Cancer

OncoTargets and Therapy
OncologyPharmacology
2019English

Significant Role of Psf3 Expression in Non-Small-Cell Lung Cancer

Cancer Science
Cancer ResearchMedicineOncology
2015English

Prognostic Significance of FoxM1 Expression in Non-Small Cell Lung Cancer

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2016English

Cytochrome P450 Expression (CYP) in Non-Small Cell Lung Cancer

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2007German

Tumor Heterogeneity Underlies Differential Cisplatin Sensitivity in Mouse Models of Small-Cell Lung Cancer

Cell Reports
BiochemistryGeneticsMolecular Biology
2019English

Non-Small Cell Lung Cancer

English

Navitoclax Enhances the Efficacy of Taxanes in Non-Small Cell Lung Cancer Models

Clinical Cancer Research
Cancer ResearchOncology
2011English

Reduced Expression of FADS1 Predicts Worse Prognosis in Non-Small-Cell Lung Cancer

Journal of Cancer
Oncology
2016English

Prognostic Significance of CD31 Expression in Patients With Non-Small-Cell-Lung Cancer

Advances in Lung Cancer
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy